Cannabis Science Inc (OTCMKTS:CBIS) has announced that it would be targeting over 1,000 acres of property, in Nevada and California. The announcement comes just days after the Proposition 64 was passed in both states. The company revealed that it plans to use to property for its drug development programs, as well as for new dispensaries and personal use. Moreover, the post election strategy of CBIS also involves signing new agreements and developing new products.

The CEO of Cannabis Science, Raymond C. Dabney, stated that the company was moving something large on a combined scale. It should be noted here that CBIS recently closed a land deal, covering an area of 300-acres. Mr. Dabney went on to reveal that there were other large land deals, in Nevada and California, in the works, which would put the company in a position accelerated growth. He also hinted that there would be several exciting announcements, very soon, which also involve the completion of an in-house laboratory and new drug development programs.

The company noted that since Nevada and California had made use of recreational marijuana legal, it would allow more pathways for customers to gain access to their products. In its press release, CBIS highlighted that the land deals were aimed towards helping the company develop more products, as demand increases in both states. Moreover, Cannabis Science is also negotiating with several dispensaries in the region, to develop a greater public outreach.

Cannabis Science was one of the first marijuana companies to have praised the results from the marijuana ballot. The company filed a separate press release, congratulating President Donald J. Trump, on his victory in the elections. In addition to Nevada and California, Massachusetts also voted in favor of recreational use of marijuana. However, the remaining states voted in favor of medical marijuana use only. Mr. Dabney highlighted that this would pave the way for marijuana based drugs to be rapidly developed and become easily available to patients, without much of the negative stigma.

Cannabis Science Inc (OTCMKTS:CBIS) had a trade volume of 106.32 million during the November 10 trading session, to reach a close at $0.0362 per share, after having declined 32.21% during the day.